{"certainAgreement":{"otherDetails":"If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"ClinicalTrialDisclosure@its.jnj.com","organization":"Aragon Pharmaceuticals, Inc.","phone":"844-434-4210","title":"Executive Medical Director"}}